18 August 2016 13:00
New external board appointment
Listing Rule LR 9.6.14 R (2)
Graham Chipchase, a Non-Executive Director of AstraZeneca PLC, has been
appointed as Chief Executive Officer and a Director of Brambles Limited, a
company listed on the Australian Securities Exchange, effective from 2017.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on
the discovery, development and commercialisation of prescription medicines,
primarily for the treatment of diseases in three therapy areas – Respiratory and
Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company
is also active in inflammation, infection and neuroscience through numerous
collaborations. AstraZeneca operates in over 100 countries and its innovative
medicines are used by millions of patients worldwide. For more information
please visit: www.astrazeneca.com
CONTACTS
Media
Enquiries
Neil UK/Global +44 203 749 5637
Burrows
Vanessa UK/Global +44 203 749 5736
Rhodes
Karen UK/Global +44 203 749 5634
Birmingham
Rob UK/Global +44 203 749 5821
Skelding
Jacob Lund Sweden +46 8 553 260 20
Michele US +1 302 885 2677
Meixell
Investor
Relations
UK
Thomas Kudsk +44 203 749 5712
Larsen
Craig Marks Finance, Fixed Income, M&A +44 7881 615 764
Nick Stone Respiratory & Autoimmunity +44 203 749 5716
Henry Oncology +44 203 749 5797
Wheeler
Christer Infection & Neuroscience +44 203 749 5711
Gruvris
US
Lindsey Cardiovascular & Metabolic Diseases +1 240 543 7970
Trickett
Mitchell Oncology +1 240 477 3771
Chan
Toll-free +1 866 381 7277
Adrian Kemp
Company Secretary
AstraZeneca PLC
-ENDS-
